T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HA
2576
DELISTED
Hawaiian Holdings, Inc.
HA
| $311K | ﹤0.01% |
16,927
-814
| -5% | -$16.5K |
|
2577
Pixelworks
PXLW
$45.7M
| $310K | ﹤0.01% |
5,875
+675
| +13% | +$38.1K |
|
2578
Kura Oncology
KURA
$896M
| $309K | ﹤0.01% |
22,077
-17,278
| -44% | -$280K |
|
2579
Camping World
CWH
$675M
| $305K | ﹤0.01% |
7,542
-734
| -9% | -$29.6K |
|
2580
GoodRx Holdings
GDRX
$1.27B
| $304K | ﹤0.01% |
9,300
-1,200
| -11% | -$48.3K |
|
|
TGH
2581
DELISTED
Textainer Group Holdings limited
TGH
| $303K | ﹤0.01% |
8,492
+1,469
| +21% | +$53.2K |
|
|
CEI
2582
DELISTED
Camber Energy, Inc
CEI
| $302K | ﹤0.01% |
7,111
-2,106
| -23% | -$135K |
|
2583
Quantum Corp
QMCO
$973M
| $301K | ﹤0.01% |
2,729
+510
| +23% | +$58.1K |
|
2584
Camden National
CAC
$996M
| $297K | ﹤0.01% |
6,165
-215
| -3% | -$10.3K |
|
|
AMRN
2585
Amarin Corp
AMRN
$299M
| $296K | ﹤0.01% |
4,387
| – | – |
|
2586
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $296K | ﹤0.01% |
3,400
| – | – |
|
|
VIRX
2587
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $296K | ﹤0.01% |
81,136
-987,676
| -92% | -$5.27M |
|
2588
Aemetis
AMTX
$126M
| $295K | ﹤0.01% |
23,986
+3,900
| +19% | +$68.9K |
|
2589
Lindsay Corp
LNN
$1.17B
| $294K | ﹤0.01% |
1,932
-193
| -9% | -$29.5K |
|
|
CANO
2590
DELISTED
Cano Health, Inc.
CANO
| $291K | ﹤0.01% |
+327
| New | +$344K |
|
2591
AAR Corp
AIR
$5.77B
| $290K | ﹤0.01% |
7,421
-523
| -7% | -$18.7K |
|
2592
Rackspace Technology
RXT
$1.1B
| $290K | ﹤0.01% |
+21,493
| New | +$307K |
|
2593
Grid Dynamics Holdings
GDYN
$644M
| $289K | ﹤0.01% |
7,605
-402
| -5% | -$13.9K |
|
2594
SkinHealth Systems
SKIN
$85.9M
| $289K | ﹤0.01% |
+11,980
| New | +$309K |
|
2595
Brookfield Infrastructure
BIPC
$5.01B
| $286K | ﹤0.01% |
6,279
-476
| -7% | -$19.7K |
|
|
PSTH
2596
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $284K | ﹤0.01% |
+14,391
| New | +$285K |
|
|
LOVE
2597
LoveSac
LOVE
$258M
| $283K | ﹤0.01% |
+4,268
| New | +$313K |
|
|
NFBK
2598
DELISTED
Northfield Bancorp
NFBK
| $282K | ﹤0.01% |
17,476
-800
| -4% | -$13.8K |
|
2599
Alpha Metallurgical Resources
AMR
$1.97B
| $281K | ﹤0.01% |
4,600
| – | – |
|
2600
American Superconductor
AMSC
$1.53B
| $281K | ﹤0.01% |
+25,859
| New | +$373K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.